Format

Send to

Choose Destination
Clin Infect Dis. 2000 Oct;31(4):1079-83. Epub 2000 Oct 25.

Empirical antimicrobial therapy for traveler's diarrhea.

Author information

1
Division of Infectious Diseases, Department of Internal Medicine, University of Texas-Houston Medical School, Houston, TX 77030, USA.

Abstract

Over 7 million cases of traveler's diarrhea, defined as the passage of > or = 3 unformed stools in a 24-h period, occur each year among visitors to developing countries. Bacterial enteric pathogens are the most common etiologic agents isolated. Preliminary clinical results for patients with diarrhea predominantly caused by Campylobacter species have shown that azithromycin may be an effective alternative to fluoroquinolones for the treatment of traveler's diarrhea.

PMID:
11049792
DOI:
10.1086/318119
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center